Samjin Pharmaceutical Officer Shin Seung-won Increases Shareholding by 400 Shares via Open Market Purchase

Samjin Pharmaceutical non-registered director Shin Seung-won acquired an additional 400 common shares through open market purchases on June 25 and June 29, 2026.
The acquisition prices were 18,200 KRW and 18,500 KRW respectively, increasing his total holdings from 600 to 1,000 shares, representing a 0.01% stake.
This is a routine insider transaction funded by personal capital, with no impact on the company's capital structure or dilution of existing shareholders.
The company's total outstanding shares remain at 13,320,000 shares with a market capitalization of approximately 255.3 billion KRW.
[AI Summary]The insider's minor share purchase may slightly improve management credibility but the negligible stake has no direct effect on stock price. This is not a material factor for investors.